The effects of fasting on glucagon binding and action in isolated rat hepatocytes

Reciprocal changes in amino acid metabolism in mammary gland and liver of the lactating rat on starvation and refeeding as indicated by the tissue accumulation of alpha-amino[1-14C]isobutyrate

Measurements of the tissue accumulation in vivo and in vitro by hepatocytes and mammary-gland acini of alpha-amino[1-14C]isobutyrate ([1-14C]AIB) were compared in virgin and lactating rats. The results indicate the existence of a reciprocal relationship between mammary gland and liver for AIB accumulation that is dependent on the lactational and the nutritional state of the rat. This suggests that amino acids are preferentially directed to the mammary gland during active lactation.

The effects of chronic uremia on glucagon binding and action in isolated rat hepatocytes

Increased liver sensitivity to glucagon has been proposed to play a role in the complex metabolic state of chronic uremia. In order to assess this possibility at the cellular level, we studied basal and glucagon-stimulated alpha-aminoisobutyric acid (AIB) uptake, glucagon binding, and glucagon degradation in isolated hepatocytes from chronic uremic and pair-fed and ad libitum-fed control rats. The uremic rats were euglycemic and hyperglucagonemic when compared with their controls. The basal rate of AIB uptake was enhanced in hepatocytes from both the uremic and pair-fed control rats. Hepatocytes from ad libitum-fed control animals responded significantly to glucagon at concentrations from 1 X 10(-11) to 1 X 10(-7) mol/L, and those from pair-fed control animals at concentrations from 1 X 10(-8) to 1 X 10(-7) mol/L. Hepatocytes from the uremic rats were unresponsive to glucagon with regard to AIB uptake. 125I-labeled glucagon binding was increased in the uremic rats. This increase of glucagon binding appears to be the results of an increase in the number of binding sites rather than a consequence of a change in binding affinity or decreased glucagon degradation. In conclusion, our data are not supportive of the hypothesis that there exists in uremia an increased sensitivity to glucagon in the liver. The uremic liver is resistant to glucagon with regard to AIB uptake. Despite the high level of circulating immunoreactive glucagon, hepatocytes from uremic rats did not show the expected "down regulation" of their 125I-labeled glucagon binding sites. These studies emphasize the primary role of post-binding events in the regulation of glucagon action and binding.

Chemical mediator of insulin action stimulates lipid synthesis and down regulates the insulin receptors in primary cultures of rat hepatocytes

Incubation of rat liver particulate fraction with insulin causes the release of a substance that stimulates lipid synthesis and down regulates the insulin receptor in primary cultures of isolated rat hepatocytes. This substance may be similar to putative mediator(s) of insulin action which has been shown to modulate the activity of key enzymes of lipid and carbohydrate metabolism in various cell free systems. Our data demonstrate that the mediator of insulin is also biologically active in an intact cell system. Down regulation of the insulin receptor by the mediator supports the concept that this phenomenon is a post binding event of insulin action.

Glucagon inhibition of insulin-stimulated 2-deoxyglucose uptake by rat adipocytes in the presence of adenosine deaminase

Effects of adenosine deaminase and glucagon on insulin-stimulated 2-deoxyglucose uptake by rat adipocytes are reported. (1) Adenosine deaminase (10 micrograms/ml) caused a rightward shift in the dose-response curve for the stimulation by insulin of 2-deoxyglucose uptake, but the enzyme did not alter either the basal or the maximally insulin-stimulated uptake rate. (2) In adipocytes obtained from 24 h-starved rats, glucagon inhibited the effect of insulin on 2-deoxyglucose uptake in the presence (but not in the absence) of adenosine deaminase. Basal uptake rates were unaffected. (3) Glucagon inhibited insulin-stimulated 2-deoxyglucose uptake to a greater extent in cells isolated from starved rats than in cells from fed rats. (4) Adipocytes isolated from fed and from starved rats did not differ in their capacity for degradation of 125I-labelled glucagon. The results suggest that adenosine and glucagon are regulators of insulin action in adipose tissue.

Glucocorticoid-induced insulin resistance: the importance of postbinding events in the regulation of insulin binding, action, and degradation in freshly isolated and primary cultures of rat hepatocytes

We have recently proposed that "down regulation" of the insulin receptor may be one of the many biological responses of a cell to insulin. In an attempt to further explore this hypothesis we have studied insulin action, binding, and degradation in freshly isolated hepatocytes from rats rendered insulin resistant by the administration of dexamethasone, 1.0 mg/kg every other day, for 1 and 4 wk, and in dexamethasone-treated (0.1 muM for 24 h) primary cultures of hepatocytes from normal rats. Dexamethasone treatment for 1 and 4 wk resulted in significant hyperinsulinemia and euglycemia when compared with age- and weight-matched control animals. Freshly isolated hepatocytes from rats treated with dexamethasone for 1 wk bound less insulin than cells from control animals. This decrease in insulin binding was reflected in a decrease in the total number of cellular insulin receptors upon solubilization of the cells. Insulin action was evaluated by the ability of insulin to stimulate the uptake of alpha-aminoisobutyric acid. The basal rate of aminoisobutyrate uptake in freshly isolated hepatocytes was enhanced by 1 wk of dexamethasone treatment, and although there was an apparent shift to the right in the dose-response curve for insulin-stimulated aminoisobutyrate uptake, at no insulin concentration was there a significant difference in the uptake by hepatocytes from control and dexamethasone-treated animals. This was true whether expressed as a percentage or absolute increment above basal. Insulin degradation was enhanced in hepatocytes from animals treated with dexamethasone for 1 wk but could not account for the observed changes in insulin binding. Hepatocytes from animals treated with dexamethasone for 4 wk were resistant to insulin with regard to aminoisobutyrate uptake, yet both insulin binding and insulin degradation returned to the levels observed in hepatocytes from control animals. Primary cultures of hepatocytes from normal rats exposed to dexamethasone, 0.1 muM, in vitro for 24 h were similar to hepatocytes from rats treated with dexamethasone for 4 wk in that they were insulin resistant with regard to aminoisobutyrate uptake and had normal to increased insulin binding. Insulin degradation was also similar. These cells were resistant to the ability of insulin, 0.1 muM, to down regulate its receptor whereas parallel cultures treated with insulin in the absence of dexamethasone had a 52% decrease in insulin binding. These data indicate that hepatocytes that are insulin responsive respond to in vivo hyperinsulinemia by a decrease in the number of insulin receptors and by increased insulin degradation. Hepatocytes rendered resistant to insulin both in vivo and in vitro are resistant to these effects of insulin. These studies emphasize the importance of postbinding events in the modulation of insulin binding, action, and degradation, and support the hypothesis that down regulation of the hepatocyte insulin receptor is one of the many biological actions of insulin. They also help explain how a cell can be insulin resistant and have a normal number of insulin binding sites in the presence of hyperinsulinemia.

Binding and action of insulin and glucagon in monolayer cultures and fresh suspensions of rat hepatocytes

Insulin and glucagon binding, and the subsequent stimulation of amino-acid transport, were investigated in adult-rat hepatocytes. Cells were used either in suspension shortly after isolation, or as monolayers after 20 h of culture in a serum-free medium. At 37 degrees C, hepatocytes in monolayer cultures bound 2.5 times as much insulin and glucagon as did freshly isolated cells, owing to an increase in the total number of binding sites per cell. For both hormones, these differences could be accounted for mainly by a greater number of low-affinity binding sites in primary cultured hepatocytes compared with freshly isolated cells. Exposure of hepatocytes to insulin or glucagon for 2-3 h at 37 degrees C in a medium free from amino acids increased the capacity (primary cultures) or induced the emergence (fresh suspensions) of a similar high-affinity component (Km approximately mM) of alpha-aminoisobutyric-acid (AIB) transport. Primary cultured hepatocytes were more sensitive to insulin (half-maximal effect occurred with insulin at approximately 0.3 nM) than freshly isolated cells (half-maximal effect approximately 0.7 nM) for the stimulation of AIB transport, whereas the dose-response curves were virtually indistinguishable for the glucagon stimulation of AIB transport in both preparations of cells (half-maximal effect occurred with glucagon at approximately 1.5 nM). These results indicate that, despite differences in the apparent insulin- and glucagon-binding capacities (which involved mainly a low affinity site), both freshly isolated and primary cultured (20-h monolayers) hepatocytes behave similarly in response to insulin and glucagon with regard to the stimulation of amino acid transport.

Insulin receptors in hepatocytes: postreceptor events mediate down regulation

Down regulation of the insulin receptor of primary cultures of rat hepatocytes occurs in the presence of insulin and several agents with insulin-like activity, which act through or distal to the insulin receptor. These findings indicate that the interaction of insulin with its specific binding site is not in itself sufficient to down-regulate this receptor and that one or more steps subsequent to this interaction are necessary. Thus, down regulation may be a complex biological response to insulin, and if a cell were resistant to this effect of insulin, our data may explain how target cells from a patient or animal can have a normal number of receptors in the presence of increased concentrations of circulating insulin.